Emageon

  
Emageon's HeartSuite 
Emageon (Booth 8537) is featuring its HeartSuite that offers an integrated suite of cardiology tools for enterprise-wide imaging, content, and information management. HeartSuite includes VERICIS image and information management system, a hemodynamics monitoring system, and CardioVascular Information System (CVIS).  VERICIS generates a digital record of images and reports for patients from cardiac catheterization, echocardiography, vascular ultrasound, and nuclear cardiology.  CVIS integrates all clinical and operational information from multiple systems and locations into one cardiology information system, while hemodynamics provides for data collection, waveform analysis, inventory control, patient charging, and procedure reporting for the catheterization lab.
 
Other HeartSuite features include ECG Management, a single interface to VERICIS for storing, analyzing, and reporting on a patient's electrocardiogram, and Echo IMS for echocardiography and information management. A Web Reporting module integrates complete cardiac patient data on a single display, while the company's 4D echo visualization and analysis functionality is designed to integrate 4D echo applications in the clinical workflow. HeartSuite also includes national registry support to simplify quality improvement efforts.

In early October, Emageon signed a definitive agreement with Health Systems Solutions (HHS) to sell 100 percent of Emageon’s stock, in an all cash transaction of approximately $62 million. The agreement was approved by HHS’ board of directors as well as Emageon’s Strategic Alternatives Committee. The merger—which is expected to close by March 31 or sooner—will result in a company of approximately 400 employees.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.